生物防禦市場：依產品、最終用戶、地區

Biodefense Market, By Product, By End User, By Geography

出版日期: 2024年06月12日 | 出版商:

Coherent Market Insights | 英文 167 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球生物防禦市場預計到2024年將達到165.1億美元，預計2031年將達到271億美元，2024年至2031年的複合年成長率為7.3%。

圖 1. 生物防禦市場佔有率(%)，依地區分類，2024 年

生物防禦涉及保護公民免受細菌、病毒、毒素和其他可用作反人類武器的生技藥品等生物威脅。生物技術的進步增加了世界各地生物恐怖主義的威脅，增加了對強大生物防禦系統的需求。生物恐怖主義是指故意使用病原微生物或毒素造成人類、動物或植物死亡或疾病。隨著生物武器變得更加先進和易於獲取，各國正在大力投資研究、檢測、預防和應對措施，以保護公眾健康。全球生物防禦市場為威脅監測、醫療對策的儲存和交付以及生物危害檢測和回應培訓提供創新的解決方案。

市場動態：

生物防禦市場是由政府和非政府組織增加投資推動的，以促進對生物威脅的準備。世界各地生物恐怖主義案例數量不斷增加，由於科學進步，生物武器的可用性不斷增加，也迫使各國加強其生物防禦基礎設施和庫存。然而，與生物防禦系統的研究、開發和採購相關的高成本限制了更廣泛的採用。此外，缺乏標準化的指導方針和法規也為市場相關人員帶來了挑戰。市場看到了加強新病原體檢測技術和治療方法研發力度的機會。經濟實惠的攜帶式檢測器的開發有可能在全部區域廣泛使用。

本研究的主要特點

該研究報告對全球生物防禦市場進行了深入分析，包括預測期內（2024-2031年，以2023年為基準年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球生物防禦市場的主要企業。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球生物防禦市場的各種策略矩陣來促進決策。

公司簡介
- XOMA corporation
- Altimmune Inc.
- Emergent Biosolutions Inc.
- Dynavax Technologies Corporation.
- SIGA Technologies.
- Elusys Therapeutics Inc.
- Ichor Medical Systems.
- Dynport Vaccine Company.
- Cleveland Biolabs.
- Bavarian Nordic.
- Ology Bioservices.
- Alnylam Pharmaceuticals Inc
- Takeda Pharmaceuticals
- Chimerix, Inc.
- Cleveland BioLabs, Inc.
- Pluristem Therapeutics

第9章分析師建議

命運之輪
分析師觀點
一致的機會圖

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI4516

The global biodefense market is estimated to be valued at USD 16.51 Bn in 2024 and is expected to reach USD 27.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

Figure 1. Biodefense Market Share (%), By Region, 2024

Biodefense involves protecting citizens from biological threats such as bacteria, viruses, toxins, and other biological agents that can be used as weapons against humanity. The rising threat of bioterrorism across the globe due to advancements in biotechnology has propelled the need for robust bio defense systems. Bioterrorism refers to the intentional use of pathogenic microorganisms or toxins to cause death or disease among humans, animals or plants. As bioweapons become more sophisticated and accessible, nations are investing heavily in research, detection, prevention and response measures to safeguard public health. The global bio defense market offers innovative solutions for threat surveillance, stockpiling and delivery of medical countermeasures, biohazard detection and response trainings.

Market Dynamics:

The bio defense market is driven by the increasing investments by government and non-government bodies to foster preparedness against biological threats. Escalating instances of bioterrorism globally and the growing accessibility of bioweapons through scientific advancement are also compelling nations to bolster their bio defense infrastructure and stockpiles. However, high costs associated with the research, development and procurement of bio defense systems limit wider adoption. Furthermore, lack of standardized guidelines and regulations pose challenges for market players. The market sees opportunities with growing R&D efforts for new pathogenic detection technologies and therapies. The development of affordable and portable bio detectors holds potential for broader usage across high-risk areas.

Key Features of the Study:

This report provides an in-depth analysis of the global biodefense market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031, considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global biodefense market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Emergent BioSolutions, SIGA Technologies Inc., Elusys Therapeutics, Inc., Altimmune, DynPort Vaccine Company LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global biodefense market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biodefense market.

Detailed Segmentation-

By Product
- Anthrax
- Small Pox
- Botulism
- Radiation
- Others
By End User
- Hospitals
- Ambulatory Care Centers
- Research Organizations
- Military
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- XOMA corporation
- Altimmune Inc.
- Emergent Biosolutions Inc.
- Dynavax Technologies Corporation.
- SIGA Technologies.
- Elusys Therapeutics Inc.
- Ichor Medical Systems.
- Dynport Vaccine Company.
- Cleveland Biolabs.
- Bavarian Nordic.
- Ology Bioservices.
- Alnylam Pharmaceuticals Inc
- Takeda Pharmaceuticals
- Chimerix, Inc.
- Cleveland BioLabs, Inc.
- Pluristem Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Biodefense Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Biodefense Market, By Product, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Anthrax
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Small Pox
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Botulism
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Radiation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Biodefense Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ambulatory Care Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Military
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Biodefense Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- XOMA corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Altimmune Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Emergent Biosolutions Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dynavax Technologies Corporation.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- SIGA Technologies.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Elusys Therapeutics Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ichor Medical Systems.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dynport Vaccine Company.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cleveland Biolabs.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bavarian Nordic.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ology Bioservices.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Alnylam Pharmaceuticals Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Takeda Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Chimerix, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cleveland BioLabs, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pluristem Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies